<DOC>
	<DOC>NCT01278693</DOC>
	<brief_summary>The purpose of this study is to determine Effect of oral L-carnitine supplement on lipid profile, anemia, and quality of life.</brief_summary>
	<brief_title>Effect of Oral L-carnitine Supplement on Lipid Profile, Anemia, and Quality of Life of Patients</brief_title>
	<detailed_description>In patients under maintenance hemodialysis several factors reduce the body stored carnitine which in turn affected dyslipidemia, anemia, and general health in these patients. The investigators evaluated the effect of oral L-carnitine supplementation on lipid profiles, anemia, and quality of life in hemodialysis patients.</detailed_description>
	<criteria>being in the age range of 1875 having the history of at least 12 weeks of hemodialysis and at least three times a week and each session almost for four hours having serum triglyceride or total cholesterol concentration &gt;200 mg/dl or serum HDL concentration &gt;40 mg/dl in the beginning of the study. taking carnitine supplement or the drug that interact with carnation lowering the seizure threshold in the last month being affected by liver function abnormalities, hypothyroidism, chronic infectious diseases (such as hepatitis), inflammatory diseases, CNS mass having the history of seizure.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Renal failure, hemodialysis, dyslipidemia, L-carnitine.</keyword>
</DOC>